Azathioprine in the prevention of anti-infliximab antibody formation: A pilot dose-finding study

被引：0
|
作者：
Kojecky, V. [1 ,2 ]
Wasserbauer, M. [3 ,4 ]
Keil, R. [3 ,4 ]
机构：
[1] Masaryk Univ, Fac Med, Brno, Czech Republic
[2] Bata Reg Hosp, Dept Internal Med, Zlin, Czech Republic
[3] Charles Univ Prague, Prague, Czech Republic
[4] Motol Univ Hosp, Dept Internal Med, Prague, Czech Republic
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P599
引用
收藏
页码：I533 / I533
页数：1
相关论文
共 50 条
  • [11] Less anti-infliximab antibody formation in paediatric Crohn's patients on concomitant immunomodulators
    Kansen, H.
    van Rheenen, P.
    Houwen, R.
    Tjon, W.
    Ten, A.
    Damen, G.
    Kindermann, A.
    Escher, J.
    Wolters, V.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S68 - S69
  • [12] Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
    de Vries, Mirjam K.
    Wolbink, Gerrit Jan
    Stapel, Steven O.
    de Vrieze, Henk
    van denderen, J. Christiaan
    Dijkmans, Ben A. C.
    Aarden, Lucien A.
    van der Horst-Bruinsma, Irene E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) : 1252 - 1254
  • [13] Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy
    Bar-Yoseph, H.
    Levhar, N.
    Selinger, L.
    Manor, U.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Eliakim, R.
    Ben-Horin, S.
    Chowers, Y.
    Ungar, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 212 - 218
  • [14] Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys
    Rojas, JR
    Taylor, RP
    Cunningham, MR
    Rutkoski, TJ
    Vennarini, J
    Jang, HS
    Graham, MA
    Geboes, K
    Rousselle, SD
    Wagner, CL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (02): : 578 - 585
  • [15] A PHENYLBUTAZONE DOSE-FINDING STUDY
    BIRD, HA
    LOWE, JR
    LEATHAM, PA
    DOWNIE, WW
    FOWLER, PD
    WRIGHT, V
    ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (06) : 621 - 622
  • [16] A pilot study in Crohn's disease comparing two strategies to prevent formation of anti-infliximab antibodies, co-administration of azathioprine and pre-treatment with IV hydrocortisone, on the long term efficacy of infliximab
    Mantzaris, Gerassimos J.
    Kalantzis, Chrysostomos N.
    Koffakou, Stavroula
    Roussos, Anastassios
    Kalafatas, John
    Apostolou, Nickolaos
    Grivas, Efstratios
    Raptis, Nickolaos
    Kalogeropoulos, John
    Kalantzis, Nickolaos
    GASTROENTEROLOGY, 2007, 132 (04) : A503 - A503
  • [17] Human pharmacology of methylone: a pilot phase I dose-finding study
    Poyatos, Lourdes
    Papaseit, Esther
    Perez-Mana, Clara
    Martin, Soraya
    Hladun, Olga
    Vila, Alexandra
    Siles, Adrian
    Fuster, Daniel
    Maria Barriocanal, Ana
    Pichini, Simona
    Farre, Magi
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 8 - 8
  • [18] An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases
    Van Stappen, Thomas
    Billiet, Thomas
    Vande Casteele, Niels
    Compernolle, Griet
    Brouwers, Els
    Vermeire, Severine
    Gils, Ann
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (09) : 2172 - 2177
  • [19] Antinuclear antibodies do not predict anti-infliximab antibody induction in sarcoidosis
    Vorselaars, Adriane Dore Marie
    Hijdra, Danielle
    van Moorsel, Coline H. M.
    Claessen, Anke M. E.
    Grutters, Jan C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (02) : 312 - 314
  • [20] An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
    van der Bijl, Arie E.
    Breedveld, Ferdinand C.
    Antoni, Christian E.
    Kalden, Joachim R.
    Kary, Sonja
    Burmester, Gerd R.
    Beckmann, Christina
    Unnebrink, Kristina
    Kupper, Hartmut
    CLINICAL RHEUMATOLOGY, 2008, 27 (08) : 1021 - 1028
12345